Back
Teradata Corp. 10K Form
Buy
91
TDC
Teradata Corp.
Last Price:
$34.43
Seasonality Move:
2.77%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-07 | 10Q | TDC/Teradata Corp. Quarterly |
| 2024-02-23 | 10K | TDC/Teradata Corp. Annual |
| 2023-11-07 | 10Q | TDC/Teradata Corp. Quarterly |
| 2023-08-08 | 10Q | TDC/Teradata Corp. Quarterly |
| 2023-05-05 | 10Q | TDC/Teradata Corp. Quarterly |
| 2023-02-24 | 10K | TDC/Teradata Corp. Annual |
Receive TDC News And Ratings
See the #1 stock for the next 7 days that we like better than TDC
TDC Financial Statistics
Sales & Book Value
| Annual Sales: | $1.7B |
|---|---|
| Cash Flow: | $151M |
| Price / Cash Flow: | 12.8 |
| Annual Sales: | $2.34 |
| Price / Book: | 16.12 |
Profitability
| EPS (TTM): | 1.34440 |
|---|---|
| Net Income (TTM): | $130M |
| Gross Margin: | $993M |
| Return on Equity: | 70.96% |
| Return on Assets: | 7.44% |
Teradata Corp. Earnings Forecast
Key Teradata Corp. Financial Ratios
-
The Gross Profit Margin over the past 22 years for TDC is 59.71%.
-
The Selling, General & Administrative Expenses for TDC have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 16.84% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of TDC is 7.82% of Total Revenues.
-
Per Share Earnings over the last 23 years have been positive in 15 years.
Teradata Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Software |
| Sector: | Information Technology |
| Current Symbol: | TDC |
| CUSIP: | 88076W |
| Website: | teradata.com |
Debt
| Debt-to-Equity Ratio: | 2.42 |
|---|---|
| Current Ratio: | 0.92 |
| Quick Ratio: | 0.81 |
Price-to-Earnings
| Trailing P/E Ratio: | 28.06 |
|---|---|
| Forward P/E Ratio: | 13.45 |
TDC Technical Analysis vs Fundamental Analysis
Buy
91
Teradata Corp. (TDC)
is a Buy
Is Teradata Corp. a Buy or a Sell?
-
Teradata Corp. stock is rated a BuyThe current Teradata Corp. [TDC] share price is $37.88. The Score for TDC is 91, which is 82% above its historic median score of 50, and infers lower risk than normal.